Viewing Study NCT01580735

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-29 @ 7:44 PM
Study NCT ID: NCT01580735
Status: COMPLETED
Last Update Posted: 2015-08-18
First Post: 2012-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer
Sponsor: Kyowa Kirin Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small-cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None c-MET View
None EGFR mutation-positive View
None gefitinib View
None erlotinib View
None EGFR-TKI resistance View